PHOENIx community pharmacy trial
Research type
Research Study
Full title
Pharmacy Homeless Outreach Engagement Non-medical Independent prescribing Rx (PHOENIx) community pharmacy based pilot randomised controlled trial
IRAS ID
309760
Contact name
Vibhu Paudyal
Contact email
Sponsor organisation
The University of Birmingham
ISRCTN Number
ISRCTN88146807
Duration of Study in the UK
1 years, 10 months, 1 days
Research summary
A randomised, multicentre, open, parallel group external pilot trial with parallel economic and qualitative process evaluation. The pilot will assess the feasibility of conducting a larger, definitive trial assessing an integrated clinical pharmacist / homeless third sector intervention (PHOENIx) delivered in a community pharmacy setting. The pilot RCT will test recruitment, retention, acceptability, trial procedures and potential future implementability and scalability of the intervention. 100 people (≥18 years) experiencing homelessness will be recruited. 15-20 of these participants will be included in a qualitative substudy, plus 7-10 health care professionals and 7-10 stakeholders. Participating pharmacies will be located in parts of Glasgow and Birmingham city centre and immediate surrounding areas
For the intervention group, in addition to usual care, the PHOENIx team (pharmacist independent prescriber in partnership with a third sector charity worker) will assess the participants’ physical, mental and addictions health, housing, benefits and social activities. The PHOENIx team will record the participant’s priorities, will assess, treat, prescribe, and refer to other health and social care teams. Participants allocated to usual care will not receive consultations from the PHOENIx team.
The primary outcome is the feasibility of a subsequent phase III trial RCT according to pre-specified progression criteria (appeal and acceptance to participants and data collection).REC name
East Midlands - Leicester South Research Ethics Committee
REC reference
22/EM/0119
Date of REC Opinion
29 Jul 2022
REC opinion
Further Information Favourable Opinion